Amanta Healthcar

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE084K01015
  • NSEID: AMANTA
  • BSEID: 544502
INR
103.24
1.42 (1.39%)
BSENSE

Dec 05

BSE+NSE Vol: 1.0 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationHalf Yearly Results
Results Snapshot
Figures in Cr
Standalone Half Yearly Results
Sep'25
Sep'24
Half Yearly Analysis Highlights
stock-summary

Net Sales

Growth in half year ended Sep 2025 is 1.01%

stock-summary

Standalone Net Profit

Growth in half year ended Sep 2025 is 147.89%

stock-summary

Operating Profit (PBDIT) excl Other Income

Growth in half year ended Sep 2025 is 8.28%

stock-summary

Interest

Growth in half year ended Sep 2025 is -27.46%

stock-summary

Operating Profit Margin (Excl OI)

Growth in half year ended Sep 2025 has improved from Sep 2024

Compare Half Yearly Results Of Amanta Healthcar With
Markets Mojo
Figures in Cr
Standalone Half Yearly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
136.19
104.82
31.37
29.93%
Other Operating Income
0.00
0.00
0.00
Total Operating income
136.19
104.82
31.37
29.93%
Raw Material Cost
47.56
64.94
-17.38
-26.76%
Purchase of Finished goods
4.64
0.00
4.64
(Increase) / Decrease In Stocks
-10.72
4.88
-15.60
-319.67%
Employee Cost
20.90
7.77
13.13
168.98%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.01
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
44.26
17.66
26.60
150.62%
Total Expenditure (Excl Depreciation)
106.65
95.25
11.40
11.97%
Operating Profit (PBDIT) excl Other Income
29.54
9.57
19.97
208.67%
Other Income
1.03
0.84
0.19
22.62%
Operating Profit (PBDIT)
30.57
10.41
20.16
193.66%
Interest
11.44
2.54
8.90
350.39%
Exceptional Items
-2.63
0.00
-2.63
Gross Profit (PBDT)
16.50
7.87
8.63
109.66%
Depreciation
9.30
3.03
6.27
206.93%
Profit Before Tax
7.20
4.84
2.36
48.76%
Tax
2.49
2.28
0.21
9.21%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
4.71
2.56
2.15
83.98%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
4.71
2.56
2.15
83.98%
Equity Capital
38.83
9.71
29.12
299.90%
Face Value
10.00
10.00
0.00
Reserves
0.00
62.80
-62.80
-100.00%
Earnings per share (EPS)
1.21
2.64
-1.43
-54.17%
Diluted Earnings per share
1.37
2.64
-1.27
-48.11%
Operating Profit Margin (Excl OI)
21.69%
9.13%
0.00
12.56%
Gross Profit Margin
12.12%
7.51%
0.00
4.61%
PAT Margin
3.46%
2.44%
0.00
1.02%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Half Yearly - Net Sales
Net Sales 136.19 Cr
in Sep 2025

Figures in Cr
Half Yearly - Standalone Net Profit
Standalone Net Profit 4.71 Cr
in Sep 2025

Figures in Cr
Half Yearly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 29.54 Cr
in Sep 2025

Figures in Cr
Half Yearly - Interest
Interest 11.44 Cr
in Sep 2025

Figures in Cr
Half Yearly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.69%
in Sep 2025

Figures in %